Package Insert (PI) Table

Please note the following when using Package Inserts from this web site:

The drug labels and other drug-specific information on this website represent the most recent drug listing information that companies have provided to, or which is obtainable by, the Division of AIDS, NIAID, NIH (“DAIDS”), and are made available here in support of DAIDS-funded and/or -sponsored clinical trials, both domestic and international.   The drug labeling, and other information is as obtainable by DAIDS and its content has neither been altered nor verified by DAIDS; as such, this content may not be Section 508 compliant.  If in the use of adaptive equipment, you encounter problems accessing the content, DAIDS will assist access through equivalent facilitation.  Please e-mail for assistance.


Drug Name Drug Company PI Date Risk List Available?
Letermovir (Prevymis) - New Merck March 2020
Hydroxychloroquine Actavis Pharma November 2017
Azithromycin Teva Pharmaceuticals May 2019
Pyrazinamide Macleods Pharmaceuticals Limited May 2014
Ethambutol Macleods Pharmaceuticals Limited July 2019
Rifampicin Macleods Pharmaceuticals Limited December 2018
Clofazimine (Lamprene) Novartis January 2019
Bictegravir/Emtricitabine/Tenofovir Alafenamide (Biktarvy) Gilead Sciences August 2019
Semaglutide (Ozempic) Novo Nordisk April 2019
Abacavir/Lamivudine (Epzicom) GlaxoSmithKline May 2019
Darunavir/Cobicistat (Prezcobix) Janssen September 2018
Ribavirin Aurobindo Pharma Limited October 2018
Rifabutin Greenstone LLC April 2018
Isoniazid Teva Pharmaceuticals USA, Inc. March 2018
Imatinib Mesylate Sun Pharmaceutical Industries, Inc. November 2018
Rifampin/Isoniazid/Pyrazinamide/Ethambutol (Rifafour e-276) Sanofi-Aventis April 2013
Pravastatin Sandoz December 2006
Levonorgestrel Northstar Rx April 2018
Intralipid Fresenius Kabi Limited April 2016
Abacavir (Ziagen) GlaxoSmithKline June 2019